These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8522585)

  • 21. Stoichiometry and stability of caldesmon in native thin filaments from sheep aorta smooth muscle.
    Marston S
    Biochem J; 1990 Dec; 272(2):305-10. PubMed ID: 2268260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity studies of the regulatory interaction of the 10 kilodalton C-terminal fragment of caldesmon with actin and the effect of mutation of caldesmon residues 691-696.
    Huber PA; Gao Y; Fraser ID; Copeland O; EL-Mezgueldi M; Slatter DA; Keane NE; Marston SB; Levine BA
    Biochemistry; 1998 Feb; 37(8):2314-26. PubMed ID: 9485378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of caldesmon on the intermediate conformational states of polymerizing actin.
    Huang R; Grabarek Z; Wang CL
    J Biol Chem; 2010 Jan; 285(1):71-9. PubMed ID: 19889635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Caldesmon and calponin are proteins, participating in the regulation of myosin and actin interaction in nonmuscle and smooth muscle cells].
    Gusev NB; Vorotnikov AV; Biriukov KG; Shirinskiĭ VP
    Biokhimiia; 1991 Aug; 56(8):1347-68. PubMed ID: 1782263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lys-373 of actin is involved in binding to caldesmon.
    Kołakowski J; Makuch R; Dabrowska R
    FEBS Lett; 1992 Aug; 309(1):65-7. PubMed ID: 1387367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caldesmon is necessary for maintaining the actin and intermediate filaments in cultured bladder smooth muscle cells.
    Deng M; Mohanan S; Polyak E; Chacko S
    Cell Motil Cytoskeleton; 2007 Dec; 64(12):951-65. PubMed ID: 17868135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of the C-terminal actin-binding sites of caldesmon on the interaction of actin with myosin].
    Vikhorev PG; Avrova SV; Ermakov VS; Copeland O; Marston SB; Borovikov IuS
    Tsitologiia; 2000; 42(11):1069-74. PubMed ID: 11204651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of caldesmon in the regulation of endothelial cytoskeleton and migration.
    Mirzapoiazova T; Kolosova IA; Romer L; Garcia JG; Verin AD
    J Cell Physiol; 2005 Jun; 203(3):520-8. PubMed ID: 15521070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mode of caldesmon binding to smooth muscle thin filament: possible projection of the amino-terminal of caldesmon from native thin filament.
    Katayama E; Ikebe M
    Biophys J; 1995 Jun; 68(6):2419-28. PubMed ID: 7647246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Caldesmon changes the structure of actin at the leading edge and suppresses cell migration].
    Kudriashova TV; Rutkevich PN; Shevelev AIa; Vlasik TN; Vorotnikov AV
    Biofizika; 2008; 53(6):978-85. PubMed ID: 19137681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification by monoclonal antibodies and characterization of human platelet caldesmon.
    Dingus J; Hwo S; Bryan J
    J Cell Biol; 1986 May; 102(5):1748-57. PubMed ID: 3517005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavior of caldesmon upon interaction of thin filaments with myosin subfragment 1 in ghost fibers.
    Borovikov YS; Wrzosek A; Kulikova N; Vikhorev P; Vikhoreva N; Dabrowska R
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):183-9. PubMed ID: 15158726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid receptor-mediated expression of caldesmon regulates cell migration via the reorganization of the actin cytoskeleton.
    Mayanagi T; Morita T; Hayashi K; Fukumoto K; Sobue K
    J Biol Chem; 2008 Nov; 283(45):31183-96. PubMed ID: 18772142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Theoretical studies on competitive binding of caldesmon and myosin S1 to actin: prediction of apparent cooperativity in equilibrium and slow-down in kinetics of S1 binding by caldesmon.
    Yan B; Sen A; Chalovich JM; Chen YD
    Biochemistry; 2003 Apr; 42(14):4208-16. PubMed ID: 12680775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detrimental effects of glucocorticoids on neuronal migration during brain development.
    Fukumoto K; Morita T; Mayanagi T; Tanokashira D; Yoshida T; Sakai A; Sobue K
    Mol Psychiatry; 2009 Dec; 14(12):1119-31. PubMed ID: 19564873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of caldesmon at the actin-myosin interface.
    Harricane MC; Fabbrizio E; Arpin C; Mornet D
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):633-7. PubMed ID: 1445222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caldesmon-actin-tropomyosin contains two types of binding sites for myosin S1.
    Sen A; Chalovich JM
    Biochemistry; 1998 May; 37(20):7526-31. PubMed ID: 9585567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of calponin and a 38-kDa caldesmon fragment on formation of the "strong-binding" state in ghost muscle fibers.
    Borovikov YS; Khoroshev MI; Chacko S
    Biochem Biophys Res Commun; 1996 Jun; 223(2):240-4. PubMed ID: 8670266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caldesmon inhibits both force development and transition of actin monomers from "OFF" to "ON" conformational state by changing its position in thin filaments.
    Pronina OE; Makuch R; Wrzosek A; Dabrowska R; Borovikov YS
    Cell Biol Int; 2007 Apr; 31(4):394-404. PubMed ID: 17321764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of ionic strength, actin state, and caldesmon construct size on the number of actin monomers in a caldesmon binding site.
    Fredricksen S; Cai A; Gafurov B; Resetar A; Chalovich JM
    Biochemistry; 2003 May; 42(20):6136-48. PubMed ID: 12755616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.